A Th17 Cell-intrinsic Glutathione/mitochondrial-IL-22 Axis Protects Against Intestinal Inflammation
Overview
Endocrinology
Authors
Affiliations
The intestinal tract generates significant reactive oxygen species (ROS), but the role of T cell antioxidant mechanisms in maintaining intestinal homeostasis is poorly understood. We used T cell-specific ablation of the catalytic subunit of glutamate cysteine ligase (Gclc), which impaired glutathione (GSH) production, crucially reducing IL-22 production by Th17 cells in the lamina propria, which is critical for gut protection. Under steady-state conditions, Gclc deficiency did not alter cytokine secretion; however, C. rodentium infection induced increased ROS and disrupted mitochondrial function and TFAM-driven mitochondrial gene expression, resulting in decreased cellular ATP. These changes impaired the PI3K/AKT/mTOR pathway, reducing phosphorylation of 4E-BP1 and consequently limiting IL-22 translation. The resultant low IL-22 levels led to poor bacterial clearance, severe intestinal damage, and high mortality. Our findings highlight a previously unrecognized, essential role of Th17 cell-intrinsic GSH in promoting mitochondrial function and cellular signaling for IL-22 protein synthesis, which is critical for intestinal integrity and defense against gastrointestinal infections.
Ferroptosis of T cell in inflammation and tumour immunity.
Xia X, Wu H, Chen Y, Peng H, Wang S Clin Transl Med. 2025; 15(3):e70253.
PMID: 40045458 PMC: 11882479. DOI: 10.1002/ctm2.70253.
Nabipur L, Mouawad M, Venketaraman V Viruses. 2025; 17(1).
PMID: 39861915 PMC: 11769047. DOI: 10.3390/v17010127.
Sex, cells, and metabolism: Androgens temper Th17-mediated immunity.
Mani N, Weinberg S J Clin Invest. 2024; 134(23).
PMID: 39621312 PMC: 11601920. DOI: 10.1172/JCI186520.
Oxidative stress in gut T17 cells makes mice susceptible to bacterial infection.
OShaughnessy S, Finlay D Immunometabolism (Cobham). 2024; 6(4):e00049.
PMID: 39544255 PMC: 11559963. DOI: 10.1097/IN9.0000000000000049.
Yuan Y, Hu H, Sun Z, Wang W, Wang Z, Zheng M Drug Des Devel Ther. 2024; 18:4273-4289.
PMID: 39347539 PMC: 11438451. DOI: 10.2147/DDDT.S473688.